Tag: Diabetic Retinopathy
- Nov 21st 2024
Managing Diabetic Retinopathy: A Guide to Nutrition and Diet
Diabetic retinopathy is the leading cause of vision loss for people with diabetes. To reduce your risk of developing this condition or to improve treatment outcomes if you've already been diagnosed, it's essential to effectively manage your …
![Diabetic Eye Disease Signs]()
![Diabetic Eye Disease Signs]()
Nov 16th 2023Early Warning Signs of Diabetic Eye Disease: Don't Ignore These Symptoms
Did you know?: November is Diabetic Eye Disease Awareness Month, established by the American Academy of Ophthalmology (AAO) to highlight the disease’s impact on vision as well as measures people can take to preserve their vision. Diabetes ranks as …
![Managing Diabetic Retinopathy]()
![Managing Diabetic Retinopathy]()
Jun 28th 2023Managing Diabetic Retinopathy: Treatment Options and Lifestyle Changes
Did you know? Research suggests that daily coffee consumption may benefit diabetic retinopathy by reducing type 2 diabetes incidence and changing the retinal microvasculature (tiny blood vessels) in adults at risk of cardiovascular issues. Although …
![JP ASRS Meeting]()
![JP ASRS Meeting]()
Jul 20th 2022Dr. Joel Pearlman Presents at the 2022 ASRS Meeting
Many RCA retina specialists are contributing to this year's annual meeting of the American Society of Retina Specialists in NYC. Among them is Retina Consultant's own Joel Pearlman, MD, PhD, pictured here moderating a session on the treatment of …
![Dreamtime image]()
![Dreamtime image]()
Nov 16th 2021November Is Diabetic Eye Disease Awareness Month
When thinking about complications of diabetes, it’s important that patients think about the effect high blood sugar has on the eyes, especially considering that the leading causes of blindness in America are diabetic eye diseases. However, the vast …
![New research at our grenback location]()
Oct 12th 2020New Research at Our Greenback Location
We are proud to announce that Dr. Margaret Chang and the Greenback RCMG study department successfully performed the first port delivery system implant in Genentech’s pivotal Pavilion study for the treatment of moderate-severe non-proliferative …
